LM
VBIV

Luminus Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Luminus Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-58,511
Closed -$2.81M – 165
2018
Q4 		$2.81M Buy
+58,511
New +$3.21M 0.06% 122

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Luminus Management's VBIV Position: Q1 2019 in Review

Luminus Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2019, closing a stake of 58,511 shares — an estimated $2.81M sold.

Luminus Management first reported a position in VBIV in Q4 2018 and held it in 1 quarter. The position peaked at $2.81M in Q4 2018. 43 funds tracked by Wall St. Rank hold VBIV as of Q1 2019.

  • Luminus Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2019 after selling out during the quarter.
  • Luminus Management sold 58,511 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2019, an estimated $2.81M.
  • Luminus Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2018 and held it in 1 quarter.
  • Luminus Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2.81M in Q4 2018.
  • 43 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2019.

Based on Luminus Management's 13F filing for Q1 2019, filed 15 May 2019.